Analyst firms · Morgan Stanley · MET
Morgan Stanley MET price target and rating history
MetLife Inc. (MET) · Finance
Morgan Stanley rates MetLife Inc. (MET) Overweight with a $79 price target, as of its latest action on Feb 22, 2022. It has published 5 rating actions on MET since July 2021, including 0 upgrades and 0 downgrades. Across 3 firms with a MET price target in the last 12 months, the median target is $101.
- Current rating
- Overweight
- Price target
- $79
- Median target, all firms
- $101
- Actions on MET
- 5
Morgan Stanley price target on MET
Every Morgan Stanley rating on MET
- Feb 22, 2022
- Jan 7, 2022
- Oct 14, 2021
- Aug 5, 2021
- Jul 15, 2021
How other firms rate MET
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Piper Sandler | Overweight | $110 | Sep 22, 2026 |
| Evercore ISI | In-line | $97 | Jan 6, 2026 |
| Mizuho | Outperform | $101 | Dec 16, 2025 |
Questions about Morgan Stanley and MET
- What is Morgan Stanley's price target for MET?
- Morgan Stanley's latest stated price target for MetLife Inc. (MET) is $79, from its action on Feb 22, 2022.
- What is Morgan Stanley's rating on MET?
- Morgan Stanley rates MET Overweight, a bullish rating, as of Feb 22, 2022.
- When did Morgan Stanley last change its view on MET?
- On Feb 22, 2022, Morgan Stanley raises its price target to $79 from $76, keeps Overweight.
- How does Morgan Stanley's MET target compare with other analysts?
- Across 3 firms with a MET price target in the last 12 months, the median target is $101.
More MET rating histories
All Morgan Stanley ratingsMET news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.